Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 4
Submit an article Journal homepage
34
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of Imipenem 1.5 g Daily in Febrile Patients with Short Duration Neutropenia After Chemotherapy for Non-leukemic Hematologic Malignancies and Solid Tumors: Personal Experience and Review of the Literature

E. Jourdan Service de Médecine Interne B, Hôpital Carémeau, rue du Professeur-Debré, 30029 CHU Nîmes, France
,
C. Defez Service de Médecine Interne B, Hôpital Carémeau, rue du Professeur-Debré, 30029 CHU Nîmes, France
,
D. Topart Service de Médecine Interne B, Hôpital Carémeau, rue du Professeur-Debré, 30029 CHU Nîmes, France
,
B. Richard Service de Médecine Interne B, Hôpital Carémeau, rue du Professeur-Debré, 30029 CHU Nîmes, France
,
H. Bellabas Service de Médecine Interne B, Hôpital Carémeau, rue du Professeur-Debré, 30029 CHU Nîmes, France
,
P. Fabbro-Peray Département d'Information Médicale, CHU Nîmes, France
,
J. Jourdan Service de Médecine Interne B, Hôpital Carémeau, rue du Professeur-Debré, 30029 CHU Nîmes, France
&
A. Sotto Service de Médecine Interne B, Hôpital Carémeau, rue du Professeur-Debré, 30029 CHU Nîmes, France
 show all
Pages 619-626 | Published online: 01 Jul 2009

  • Bodey, G.P., Alvarez, M.E., Jones, P.O., Rolston, K.V., Steethammer, I., and Fainstein, V. (1986) "Imipenem-cilastatin as initial therapy for febrile cancer Patients, Antimicrobiol Agents and Chemotherapy 30(2). 211-214.
  • Nonrby, S.R., Vandercam, B., Louie, T., Runde, V., Norberg, B., Anniko, M., Andrien, K. Baudrihaye, M. Bow, E., Burman, L.A., Bury, J., Ezzedine, H., Gigi, J., Grandlund, M. Holm, J., Lundberp, S., Michaux, J.L., Le Saux, N., Wahlin, A. and Zarikrisson, K. (1987) "Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective. randomized multi-clinic study", Scandinavian Journal of infectious Diseases (Suppl. 52), 65 -78.
  • Mortimer, J., Miller, S., Black, D., Kwok, K. and Kirby, W.M. (1988) "Comparison of cefoperazone and mezlocillian with imipenem as empiric therapy in febrile neutropenic cancer patients". American Journal of Medicine 85(1A). 17-20.
  • Liang, R., Yung, R., Chau, P.Y., Chan, T.K., Lam, W.K., So, S.Y. and Todd, D. (1988) "Imipenem/cilastatin as initial therapy for febrile neutropeuio patients". Journal of Antimicrobiol Chemotherapy 22(5), 765-770.
  • Vandercam, B., Ezzeddine, H., Agaliotis, D., Gala, J.L., Gigi, J., Waiuers, G. and Michaux, J.L. (1989) "Imipenem/cilastatin versus piperacillin plus ainikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with haematologic malignancies". Acta Clinica Belgica 44(2), 99-109.
  • Liu, C.Y. und Wang, F.D. (1989) "A comparative study of ceftriaxone plus amikacin. ceftazidime plus amikacin and imipenem/cilastatin in the empiric therapy of febrile granulocytopenic cancer patients", Chemotherapy 35(Suppl. 2). 16-22.
  • Hathorn, J.W. (1989) "Empirical antibiotics for febrile neutropenic cancer patients". European Journal of Cancer and Clinical Oncology 25(Suppl. 2), S43-S51.
  • Liang, R., Yung, R., Chiu, E., Chau, P.Y., Chan, T.K., Lam, W.K. and Todd, D. (1990) "Ceftazidime versus imipenem-cilastatin as initial monotberapy for febrile neutropenic patients". Antimicrobial Agents and Chemotherapy 34(7). 1336-1341.
  • Mortimer, J., Black, D. and Fijalka, S. (1991) "Comparison of cefoperazone and mezlocillin with imipenem-cilastatin in febrile neutropenic patients with cancer". Current Therapeutic Research 49, 701 710.
  • Matsui, K., Masuda, N., Takada, M., Kusunoki, Y. and Fukuoka, M. (1991) "A randomized trial comparing imipenem/cilastatine alone with latamoxef plus tobramycin in febrile neutropenic patients with lung cancer". Japanese Journal of Clinical Oncology 21(6). 428 -434.
  • Leyland, M.J. Bayston, K.F., Cohen, J., Warren, R., Newland, A.C., Bint, A.J., Cefai, C., White, DG., Murray, S.A., Bareford, D. and Deaney, N.B. (1992) "A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies". Journal of Antimicrobiol Chemotherapy 30(6), 843-854.
  • Cornelisscn, J.J. de Graeff, A. Verdnnck. LF. Rranger, T., Rozenberg-Arska, M., Verhoef, J. and Dekker, A.W. (1992) "Imipenem versus gentamicin combined with either cefuroxiaie or cephalothin as initial therapy for febrile neutropenic patients", Antimicrobial Agents and Chemotherapy 36(4), 801-807.
  • Bosseray, A., Nicolini, F., Brion, J.P., Michallet, M., Bollard, D., Stahl, J.P. and Micoud, M. (1992) "Evaluation of three types of empirical antibiotherapy in patients with febrile neutropenia: imipenem-cilastatin versus ceftazidiroe-vancornycin versus ticaicillin-amikacin-vancomycin", Pathologic Biolngie 40(8). 797-804.
  • Rolston, K.V., Berkey, P., Bodey, G.P., Anaissie, E.J., Khardori, N.M., Joshi, J.H., Keating, M.J., Holmes, P.A., Cabanillas, F.F. and Citing, L. (1992) "A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients". Archives of Internal Medicine 152(2). 283-291.
  • Miller, J.A., Butler, T., Beveridge, R.A., Kales, A.N., Binder, R.A., Smith, I.,J., Ueno, W.M., Milkovich, G., Goldwater, S., Marion, A., Eron, L., Mangi, R., Byrnes, C.A., Liss, C. and Pashko, S. (1993) "Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients". Clinical Therapeutics 15(3). 486-499.
  • Au, E., Tow, A., Men, D.M. and Ang, P.T. (1994) "Randomised study comparing imipenem/cilastatin to ceftriaxone plus gentamicin in cancer chemotherapy-induced neutropenic fever". Annal., of the Academy of Mediane 23(6). 819 -822. Singapore.
  • Kojima, A., Shinkai, T., Soejima, Y. Okamom, H., Fguchi, K., Sasaki, Y. Tamura, T., Oshita, F. Ohe, Y. and Saijo, N. (1994) "A randomized prospective study of imipenem-cilastatin with or without amikacin as an empirical antibiotic treatment for febrile neutropenic patients", American Journal of Clinical Oncology 17(5). 400 404.
  • Erjavec, Z., de Vries-Hospers, H.G., van Kamp, H., van der Waaij, D., Halie, M.R. and Daenen, S.M. (1994) "Comparison of imipenem versus cefuroxime plus tobramycin as empirical therapy for febrile granulocytopenic patients and efficacy of vancomycin and aztreonam in case of failure". Scandinavian Journal of Infectious Diseases 26(5), 585-595.
  • Perez, C., Sirham, M., Labarea, J., Grebe, G., Lira, P., uliva, J. Duhalde, M., Ocqueteau, M. and Acuna, G. (1995) "Imipenem/ cilastatin versus cefiazidime-amikacin in the treatment of febrile neutropenic patients". Revista Medica de Chile 123(3). 312 320.
  • Fretfeld, A.G., Walsh, T., Marshall, D., Gress, J., Slemberg, S.M., Hathorn, J., Rubin, M., Jarosinski, P., Gill, V., Young, R.C and Pizzo, P.A. (1995) "Monotherapy tor fever and neutropenia in cancer patients: a randomized comparison of ceflazidime versus imipenem", Journal of Clinical Oncology 13(1). 165-176.
  • Aparicio, J., Oltra, A., Lloica, C., Momalar, J., Herranz, C., GoroezCodina, J., Pastor, M. and Munarriz, B. (1996) "Randomised comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic cancer patients". European Journal of Cancer 32A(10), 1739-1743.
  • Shah, P.M., Heller, A., Fuhr, H.G., Walther F., Halir, S., Schaumann, R., Böhme, A., Jung, B. Kohler, A., Lip s-Schulte, C. and Stille, W. (1996) "Empirica l monotherapy with mciopenem versus imipenem/cilaslatin for febrile episodes in neurropcnic patients". Infection 24(6), 480-484.
  • Winston, D.J.,Bartoni, K., Bruckner, D.A., Schiller, G.J. and Territo, M.C. (1998) "Randomized comparison of sulbactam/cefoperaone with imipenem as empirical monotherapy for febrile granulocytopenic patients". Clinical Infectious Diseases 26(3), 576-583.
  • Biron, P., Fuhrmann, C., Cure, H., Viens, P., Lefebvre, D., Thyss, A., Viot, M., Soler-Michel, P., Rollin, C. and Gres, J.J. (1998) "Cefepime versus imipenein-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropcnia. CEMIC (Study Group of Infectious Diseases in Cancer)". Journal of 'Antimicrobiol Chemotherapy 42(4), 511-518.
  • Dietrich, E.S., Patz, E., Frank, U. und Daschner, F.D. (1999) "Costeffectiveness of ceftazidime or imipenem/cilaslatin versus ceflriaxone + aminoglycoside in the treatment of febrile episodes in neutropenic cancer patients in Germany". Infection 27(1). 23-27.
  • Ozyilkan, O., Yaleintas, U. and Baskan, S. (1999) "Imipeneincilastatin versus sulbaclam-cefoperazone plus amikacin in the initial treatment of febrile neulropenic cancer patients", Korean Journal of Internal Medicine 14(2), 15-19.
  • Winston, D.J., Lazarus, H.M., Beveridge, R.A., Halhom, J.W., Gucalp, R., Ramphal, R., Chow, A.W., Ho, W.G., Horn, R., Feld, R., Louie, T.J., Terrilo, M.C., Blumer, J.L. and Tack, K.J. (2001) "Randomized, double-blind, multicenter trial comparing clinafloxacin with imipenem as empirical monotherapy for febrile granulocytopenic patients". Clinical Infectious Diseases 32(3). 381-390.
  • Buhme, A., Just-Nubling, G., Bergmann, L., Shah, P.M., Stille, W. and Hoelzer, D. (1995) "A randomized study of imipenem compared to cefotaxime plus piperticillin as initial therapy of infections in granulocytopenic patients". Infection 23(6). 349-355.
  • Böhme, A., Shah, P.M., Stille. W and Hoelzer, D. (1998) "Prospective randomized study to compare imipenem 1.5grams per day vs, 3.0 grains per day in infections of granulocytopenic patients". Journal of Infection 36(1), 35-42.
  • Freifeld, A., Marchigiajii, D., Walsh, T., Chanock, S., Lewis, L., Hiemenz, J., Hiemenz, S., Hicks, J.E., Gill, V., Steinberg, S.M. and Pizzo, P.A. (1999) "A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutmpenia during cancer chemotherapy". New England Journal of Medicine 341(5). 305-311.
  • Minotti, V., Gentile, G., Bucaneve, G., Iori, A.P., Micozzi, A., Cavichi, F., Barbobietola, G., Landonio, G., Menichetti, F., Manino, P. and Del Favero, A. (1999) "Domiciliary treatment of febrile episodes in cancer patients: a prospective randomized trial comparing oral versus parenteral empirical antibiotic treatment". Supportive Care in Cancer 7(3), 134-139.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.